Respiratory Immunopharmacology
21 – 30 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Proteomic analysis of food allergens
2022) p.225-300(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic
(
- Contribution to journal › Article
- 2021
-
Mark
Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses
(
- Contribution to journal › Article
-
Mark
Imiquimod shows anti-viral actions in human bronchial epithelium - implications for COVID-19 treatment
2021) European Respiratory Society (ERS) congress 2021(
- Contribution to conference › Poster
-
Mark
Efficacy of mepolizumab in usual clinical practice and characteristics of responders : Mepolizumab in usual clinical practice
(
- Contribution to journal › Article
-
Mark
Mast cell tryptase enhances wound healing by promoting migration in human bronchial epithelial cells
(
- Contribution to journal › Article
-
Mark
Lung transplant after 6 months on ECMO support for SARS-CoV-2-induced ARDS complicated by severe antibody-mediated rejection
(
- Contribution to journal › Article
-
Mark
Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma
(
- Contribution to journal › Article
-
Mark
Imaging biomarkers in animal models of drug-induced lung injury : A systematic review
(
- Contribution to journal › Scientific review
- 2020
-
Mark
No gender-related bias in COPD diagnosis and treatment in Sweden : a randomised, controlled, case-based trial
(
- Contribution to journal › Article